SCHEMBL6296325

SCHEMBL6296325

CC1CC(C)(C)NC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.33
RECQL P46063 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16948385 0.72
SCHEMBL5470718 0.72
SCHEMBL327787 0.69 RECQL (0.38) ALPLRECQLALOX15
SCHEMBL24952237 0.69
SCHEMBL10341130 0.69 ALOX15 (0.37) RECQLALOX15
SCHEMBL21203063 0.69
SCHEMBL24953247 0.69
SCHEMBL9491790 0.69
SCHEMBL17924952 0.69 RECQL (0.34) RECQLALOX15
SCHEMBL530755 0.69 RECQL (0.30) RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0263561-B1 Silylated u.v. stabilizers containing hindered tertiary amines GREAT LAKES CHEMICAL ITALIA (IT) 1998-05-13 EP claimed
US-4946880-A SILICIC FUNCTIONAL N-SUBSTITUTED PIPERIDINE, MORPHOLINE OR PYROLIDINE COMPOUNDS ENICHEM SYNTHESIS S.P.A. (IT) 1990-08-07 US claimed
US-4797451-A VINYL AROMATIC, HINDERED POLYETHER OR DIENE-OLEFIN POLYMERS MODIFIED WITH HINDERED AMINES ENIRICERCHE S.P.A. (IT) 1989-01-10 US claimed
EP-0162524-B1 ORGANIC POLYMER STABILISATION ENICHEM SYNTHESIS S.p.A. (IT) 1988-11-02 EP claimed
EP-0218298-A2 Solid polymeric stabilizer compounds and process for their manufacturing ENIRICERCHE S.p.A. (IT) 1987-04-15 EP claimed
EP-0162524-A2 Organic polymer stabilisation ENICHEM SYNTHESIS S.p.A. (IT) 1985-11-27 EP claimed
US-6903117-B2 Indole derivatives for the treatment of osteoporosis NIKEM RESEARCH S.R.L. (IT) 2005-06-07 US disclosed
US-20040010012-A1 Selective inhibitor of the biological activity of human osteoclast cells SMITHKLINE BEECHAM SPA 2004-01-15 US disclosed
US-20020173659-A1 Indole derivatives for the treatment of osteoporosis SMITH KLINE BEECHAM SPA 2002-11-21 US disclosed
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
US-5905148-A Photochromic spirooxazine polysiloxanes YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1999-05-18 US disclosed
EP-0914321-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1999-05-12 EP disclosed
EP-0263561-B1 Silylated u.v. stabilizers containing hindered tertiary amines GREAT LAKES CHEMICAL ITALIA (IT) 1998-05-13 EP disclosed
US-4853440-A ULTRAVIOLET RADIATION SCREENS FOR PROPYLENE ENIRICERCHE, S.P.A. (IT) 1989-08-01 US disclosed
US-4797451-A VINYL AROMATIC, HINDERED POLYETHER OR DIENE-OLEFIN POLYMERS MODIFIED WITH HINDERED AMINES ENIRICERCHE S.P.A. (IT) 1989-01-10 US disclosed
EP-0162524-B1 ORGANIC POLYMER STABILISATION ENICHEM SYNTHESIS S.p.A. (IT) 1988-11-02 EP disclosed
EP-0263561-A2 Silylated u.v. stabilizers containing hindered tertiary amines GREAT LAKES CHEMICAL ITALIA S.r.l. (IT) 1988-04-13 EP disclosed
US-4684726-A TO STABILIZE POLYOLEFINS AND POLYDIENES ENICHEM SINTESI, S.P.A. (IT) 1987-08-04 US disclosed
EP-0218298-A2 Solid polymeric stabilizer compounds and process for their manufacturing ENIRICERCHE S.p.A. (IT) 1987-04-15 EP disclosed
EP-0162524-A2 Organic polymer stabilisation ENICHEM SYNTHESIS S.p.A. (IT) 1985-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040010012-A1 Selective inhibitor of the biological activity of human osteoclast cells HRH4, HRH3, CNKSR1 ALPL 1540/4885RECQL 3503/4885ALOX15 4154/4885
US-20020173659-A1 Indole derivatives for the treatment of osteoporosis SOST, GHRHR, EBP ALPL 587/4885RECQL 2474/4885ALOX15 3171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.